This Startup Wants To Catch Cancer Before It Spreads
Billion to One, founded by two PhD students, has developed ultra-sensitive genetic testing technology that detects rare DNA signals in blood—such as fetal DNA during pregnancy or tumor DNA in cancer—with unprecedented precision, enabling non-invasive prenatal screening and a path toward e
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Products & Tools
Topics
Listen to This Episode
More from Y Combinator Startup Podcast
Inside The Startup Reinventing America’s Trillion Dollar Chemical Industry
How to Build an AI-Native Services Company
Inside The Startup Building Reusable Rockets
How To Get Your First Customers
The Future Of Brain-Computer Interfaces with Science's Max Hodak
This Startup Secretly Detects Fraud For Fortune 500s
Related episodes
From other shows on similar topics.
Sell One Level Up to Scale Faster | Ep 942
The Game with Alex Hormozi
The French Industrialist Betting on Robotics to Cure Disease (And the Ethical Line He Won’t Cross) | Ep. 316 with Hervé de Malliard President of Maison MGA
Founder's Story
Fertility Inc.: The Embryo Editing Dinner
The Journal.
664. Are Thousands of Medical Cures Hiding in Plain Sight?
Freakonomics Radio
Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
Huberman Lab
$10M Business ideas w/ The Most Interesting Guy In Tech
My First Million
Get summaries like this every morning.
Free AI-powered recaps of Y Combinator Startup Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.